Canopy Growth Corporation (CGC) rose 88 cents to $21.13 on 6.7 million shares Thursday. The company announced a new hemp-derived CBD product line. The stock bounced off the bottom of its declining channel last month, and has since been consolidating before breaking out of the channel earlier this week. A move through recent highs in the $21.50-.70 area could lead to our next target of $26.
Mallinckrodt plc (MNK) jumped 33 cents, or nearly 10%, to $3.69 on 7.6 million shares Thursday. The UK-based biopharmaceutical company last week announced findings on a novel predictive model to more quickly identify infants with a rare seizure disorder. A break through lateral resistance in the $4-$4.15 range could accelerate the stock to $5.25.
(more…)



